BHCM
Brevan Howard Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.56M | Buy |
+163,252
| New | +$7.56M | 0.04% | 195 |
|
|
2025
Q1 | – | Sell |
-142,886
| Closed | -$8.08M | – | 1133 |
|
|
2024
Q4 | $8.08M | Buy |
142,886
+106,230
| +290% | +$6.01M | 0.05% | 64 |
|
|
2024
Q3 | $1.9M | Buy |
36,656
+30,129
| +462% | +$1.56M | 0.01% | 243 |
|
|
2024
Q2 | $271K | Buy |
+6,527
| New | +$271K | ﹤0.01% | 763 |
|
|
2024
Q1 | – | Sell |
-18,098
| Closed | -$929K | – | 978 |
|
|
2023
Q4 | $929K | Buy |
18,098
+1,245
| +7% | +$63.9K | 0.01% | 214 |
|
|
2023
Q3 | $978K | Buy |
+16,853
| New | +$978K | 0.01% | 46 |
|